Emergent BioSolutions (EBS) Intangibles (2013 - 2026)

Emergent BioSolutions' Intangibles history runs 14 years deep, the most recent figure standing at $470.4 million for Q1 2026.

• In Q1 2026, Intangibles fell 3.05% year-over-year to $470.4 million; the TTM figure through Mar 2026 stood at $470.4 million (down 3.05% YoY), while the FY2025 annual figure was $436.5 million, down 12.96% from the prior year.
• Intangibles was $470.4 million for Q1 2026 at Emergent BioSolutions, up from $436.5 million in the prior quarter.
• In the past five years, Intangibles ranged from a high of $728.8 million in Q4 2022 to a low of $436.5 million in Q4 2025.
• Historically, Intangibles has averaged $552.3 million across 5 years, with a median of $550.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Intangibles advanced 20.54% in 2022, then declined 22.26% in 2023.
• A 5-year view of Intangibles shows it stood at $728.8 million in 2022, then retreated by 22.26% to $566.6 million in 2023, then declined by 11.49% to $501.5 million in 2024, then fell by 12.96% to $436.5 million in 2025, then increased by 7.77% to $470.4 million in 2026.
• The last three Intangibles figures came in at $470.4 million (Q1 2026), $436.5 million (Q4 2025), and $452.7 million (Q3 2025), per Business Quant data.